President and CEO of Michigan Biotechnology Institute (MBI) in Lansing. MBI's focus is in industrial or white biotechnology, the production of fuels, chemicals, polymers, proteins, and other materials from renewable resources. A nonprofit organization, MBI developed the concept of "de-risking," a systematic, trans-disciplinary approach designed to bridge the gap between research and commercial application for promising bio-based technologies. MBI became a wholly owned subsidiary of the Michigan State University (MSU) Foundation in 2005 and a member of the MSU BioEconomy Network. It has an integrated laboratory, a staff of 30, and collaborates with university and industry partners to accelerate the commercialization of bio-based technologies. Under Bringi's leadership, MBI is receiving up to $4.3 million to improve pre-treatment processes in biofuels development from the Department of Energy's Biomass Program as part of the Obama administration's efforts to cut foreign oil imports. In addition, the U.S. Department of Agriculture honored MSU for being one of the greenest green research institutions in the country, recognizing MSU and MBI researchers for developments in sustainable fuel and agriculture. Previously, Bringi cofounded and built Phyton, a biotechnology company with U.S. and German R&D and manufacturing operations. Phyton pioneered and commercialized plant cell fermentation technology to produce the anti-cancer drug paclitaxel and developed long-term supply and licensing partnerships. Bringi has been a featured speaker with groups such as the Milken Institute Global Conference, TEDx Lansing, and the Pacific Rim Summit on Industrial Biotechnology and Bioenergy. He is an adjunct visiting professor in chemical engineering and material science at MSU and serves on the advisory board at Cornell University's School of Chemical Engineering. Majoring in chemical engineering, Bringi received his bachelor's degree from Banaras Hindu University's Institute of Technology, master's from Colorado State University, and PhD from Cornell.